ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

ACS Probably Will Accept Hammer’s Offer On Matching Funds For Survey

February 3, 1984

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

New Research Grant Awards

October 18, 1974